SG11201505590TA - An antiviral pharmaceutical composition - Google Patents

An antiviral pharmaceutical composition

Info

Publication number
SG11201505590TA
SG11201505590TA SG11201505590TA SG11201505590TA SG11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA SG 11201505590T A SG11201505590T A SG 11201505590TA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
antiviral pharmaceutical
antiviral
composition
pharmaceutical
Prior art date
Application number
SG11201505590TA
Inventor
Abu Bakar Sazaly Bin
Yuen Suen Sherman Lam
Yee Koon Antony Tan
Original Assignee
Herbitec M Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbitec M Sdn Bhd filed Critical Herbitec M Sdn Bhd
Publication of SG11201505590TA publication Critical patent/SG11201505590TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11201505590TA 2013-01-17 2014-01-08 An antiviral pharmaceutical composition SG11201505590TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2013700109A MY169312A (en) 2013-01-17 2013-01-17 An antiviral pharmaceutical composition
PCT/MY2014/000004 WO2014112861A1 (en) 2013-01-17 2014-01-08 An antiviral pharmaceutical composition

Publications (1)

Publication Number Publication Date
SG11201505590TA true SG11201505590TA (en) 2015-08-28

Family

ID=51209875

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201505590TA SG11201505590TA (en) 2013-01-17 2014-01-08 An antiviral pharmaceutical composition

Country Status (4)

Country Link
AU (1) AU2014207946A1 (en)
MY (1) MY169312A (en)
SG (1) SG11201505590TA (en)
WO (1) WO2014112861A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106692127B (en) * 2016-12-12 2021-01-15 东莞广州中医药大学中医药数理工程研究院 Application of luteolin in preparation of medicine for preventing and treating dengue fever virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605135B2 (en) * 2003-11-10 2009-10-20 The University Of Hong Kong Baicalin as a treatment for SARS infection
WO2009097512A1 (en) * 2008-02-01 2009-08-06 Innovative Drug Discovery Inc. Herbal pharmaceutical compositions to treat inflammation and inflammation associated conditions and diseases
MY151083A (en) * 2012-03-30 2014-04-04 Univ Malaya Antiviral composition against flavivirus

Also Published As

Publication number Publication date
AU2014207946A1 (en) 2015-08-06
WO2014112861A1 (en) 2014-07-24
MY169312A (en) 2019-03-21

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
HK1225716A1 (en) Antiviral compounds
PL3030262T3 (en) Combined pharmaceutical composition
PL2943181T3 (en) Pharmaceutical compositions
HK1216885A1 (en) Antiviral compounds
PL3043778T3 (en) Pharmaceutical compositions containing refametinib
ZA201408333B (en) Pharmaceutical compositions
EP2990038A4 (en) Solid pharmaceutical composition
HK1217943A1 (en) Antiviral compounds
SG11201601477VA (en) Pharmaceutical composition
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
HRP20171888T1 (en) Pharmaceutical compositions
HUP1300496A2 (en) Stable pharmaceutical composition
HK1220143A1 (en) Pharmaceutical composition
ZA201509091B (en) Antivirally effective pharmaceutical composition
EP2950789A4 (en) Antiviral compounds
SG11201505590TA (en) An antiviral pharmaceutical composition
HK1217200A1 (en) Antiviral compounds
HK1216884A1 (en) Antiviral compounds
GB201304699D0 (en) Pharmaceutical compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201316662D0 (en) Pharmaceutical Combination
GB201311373D0 (en) Antiviral drug derivatives
GB201311374D0 (en) Antiviral Drug Derivatives